Hints and tips:
Showing results for MAYNE PHARMA (USA) INC.
...In particular, WBA pointed to a 2.3 per cent year-on-year rise in sales at its main Retail Pharmacy USA division, with a rise in pharmacy sales offsetting declining retail sales....
...Our 10% WACC remains a premium to our mid-cap pharma peer average 8.6% which reflects our view of increased risk around single product execution....
...Campari will be hard hit by COVID-19 due to high On Trade exposure, especially in core markets of Italy and the USA....
...In September last year, Novartis said it would sell parts of the Sandoz US business to Aurobindo Pharma USA to focus on “higher growth areas”....
...On Thursday, Novartis said it would sell portions of the Sandoz US portfolio to Aurobindo Pharma USA in order to focus on “higher growth areas”....
...In April last year Fresenius, a large German medical products group, announced an acquisition of American generics pharma company Akorn for nearly $5bn....
...The companies now under investigation are: Heritage Pharmaceuticals, Inc.; Aurobindo Pharma USA, Inc.; Citron Pharma, LLC; Mayne Pharma (USA), Inc.; Mylan Pharmaceuticals, Inc.; Teva Pharmaceuticals USA;...
...Australian generic drug maker Mayne Pharma Group, which derives 87 per cent of its revenue from the United States according to Bloomberg data, dropped 2.6 per cent....
.... ———- Chartwatch Drug donations Pharma companies provide more than 1.8bn treatments a year for neglected tropical diseases....
...The states’ lawsuit said that the six generic drug makers – which also include Heritage Pharmaceuticals, Aurobindo Pharma USA, Citron Pharma and Mayne Pharma – “entered into illegal conspiracies in order...
...Mayne Pharma shed 2.6 per cent....
...Mayne Pharma into the top 25 retail generic pharmaceutical companies and the top 2 in the generic oral contraceptives market in the United States.”...
...The move quickly spurred market speculation that Mr Son would revive talks for a merger between SoftBank-owned Sprint and rival T-Mobile USA....
...KKR will acquire the minority stake in Gland Pharma, including the entire stake held by private equity fund, Evolvence India Life science Fund, in the Hyderabad-based firm, KKR said in a statement.”...
...Related reading: Ranbaxy: losses, again, beyondbrics India pharma: Strides Arcolab in $1.6bn deal with US generics maker Mylan, beyondbrics India: pharma companies sales to suffer on new round of price controls...
...Nestlé is not the first to face this sort of problem – razor makers, printer manufacturers and pharma companies all like to tie customers in to buying their consumables, but face competition from generic...
...Symbion was created in 2005 from the split of Australia’s Mayne Group into hospital and pharmaceuticals units. In January, Mayne Pharma was acquired by US group Hospira for A$2bn....
...Mayne Pharma’s shares closed at A$4.16, compared with the A$4.10 a share offered by Hospira, which represented a 32 per cent premium over the closing price on Monday, before Mayne shares were suspended from...
...Shares of Mayne Pharma soared 36 per cent on the news on Thursday. On Wednesday, Hospira shares rose 1.9 per cent to $37.55....
...David Drane, Dorset Tim Price: The gloom in relation to US Inc is probably overdone....
...Pharma, an Australian supplier of generic drugs....
...Hospira, the US pharmaceuticals group, last month said it was in advanced talks to acquire Mayne Pharma, the Australian injectable drugs specialist, in a deal worth about US$2bn....
...Meanwhile, Hospira, a spin-off from Abbott, offered A$2.5bn in cash for Mayne Pharma, an Australian supplier of generic drugs....
...Her new job is head of external communications at Mayne Pharma, a specialist in injectable cancer drugs. mudlark@ft.com...
...Larry Lynch, USA Tom Glocer: I think there’s always going to be a role for newspapers....
International Edition